Insitro
Technology
Company overview
Insitro is a drug discovery company. It combines cellular experiments with population genetics and artificial intelligence to develop targeted therapeutics. The company is based in San Francisco, in the United States.
Daphne Koller founded Insitro in 2018. Its stated goal is to bring better drugs to patients faster, using large, high-quality, multi-modal datasets. That matters: Insitro is betting that better data, not just bigger models, is what leads to new drugs. Historically, the median salary is ~$222,250. Insitro is an H-1B sponsor.
- Industry
- Technology
- Headquarters
- San Francisco, United States